Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07342582 · ClinicalTrials.gov registry record
The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study
A clinical trial, sponsored by University of Wisconsin, Madison.
- Not yet
- Registry status
- 670
- Enrollment target
NCT07342582: Clinical Trial study, sponsored by University of Wisconsin, Madison.
NCT07342582 is a clinical trial that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 670 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07342582 has not yet begun recruiting, sponsored by University of Wisconsin, Madison.
- NOT YET RECRUITING
- Registry status
- 670 participants
- Enrollment target
Study Summary
The goal of this study is to determine the burden of Rhinoviruses (RVs) as a cause of acute, severe, respiratory illnesses leading to hospitalization. A community cohort of 120 children between 12 and 36 months of age will be enrolled in the first year of the study and followed (when well and sick) for 36 months to identify the circulating RVs and provide samples to establish a host nasal transcriptome differentiating clinical from subclinical RV infections. A hospitalized cohort of 450 infants and children will be enrolled during years 1 through 3 of the study and followed for the duration of their hospitalization to investigate the findings of the community cohort. An additional 100 healthy children aged 5-17 years will be enrolled for age-match comparison with the older hospitalized cohort.
Primary Outcome
To test study hypotheses, the study team will identify the circulating RV types in symptomatic and asymptomatic children.
Interventions
- DIAGNOSTIC_TEST Nasal Swab Healthy Surveillance
- DIAGNOSTIC_TEST Nasal Swab Sick Samples
- DIAGNOSTIC_TEST Nasal Swab Hospitalized Cohort
- OTHER Sick Follow-up Survey
- OTHER Older Cohort Control Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 670 participants |
| Start Date | 2026-05 |
| Est. Completion | 2030-05 |
What is known before NCT07342582 opens enrollment
NCT07342582 is an observational study that tracks outcomes without assigning an intervention. The registered 670 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Nasal Swab Healthy Surveillance is the first listed.
NCT07342582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07342582 about?
NCT07342582 is a clinical study titled "The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study". The goal of this study is to determine the burden of Rhinoviruses (RVs) as a cause of acute, severe, respiratory illnesses leading to hospitalization. A community cohort of 120 children between 12 and 36 months of age will be enrolled in the first year of the study and followed (when well and sick) ...
What is the current status of trial NCT07342582?
This trial is currently not yet recruiting. The enrollment target is 670 participants. The study started on 2026-05. Estimated completion is 2030-05.
What interventions are being tested in trial NCT07342582?
The interventions under investigation include: Nasal Swab Healthy Surveillance (DIAGNOSTIC_TEST), Nasal Swab Sick Samples (DIAGNOSTIC_TEST), Nasal Swab Hospitalized Cohort (DIAGNOSTIC_TEST), Sick Follow-up Survey (OTHER), Older Cohort Control Group (OTHER).
Who is sponsoring clinical trial NCT07342582?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02984761 · 670 participants · NA
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- NCT05727904 · 670 participants · Phase 3
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- NCT06223867 · 670 participants · NA
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
- NCT07184944 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia